Dana-Farber Cancer Insititue

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Choriocarcinoma

Studies at this site

• TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma — Completed